Discover
NNNN
Anbio Biotechnology
4.66
1 x 11.55
1 x 9.89
bid
ask
+
0.04
0.87%
1 @ 04:00 PM
4.66 +0.00 (0.00%)
| Ytd | -84.50% | |
| 1y | -84.25% |
4.20
day range
5.16
4.62
52 week range
41.11
| Open | 4.63 | Prev Close | 4.62 | Low | 4.20 | High | 5.16 | Mkt Cap | 204.53M |
| Vol | 69.81K | Avg Vol | 146.84K | EPS | 0.15 | P/E | 31.07 | Forward P/E | N/A |
| Beta | 5.31 | Short Ratio | 1.79 | Inst. Own | 4.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-28 | 50-d Avg | 7.34 | 200-d Avg | 19.75 | 1yr Est | 0.00 |
| Income Statement | |||
| Weighted Average Shares | 43.67M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.77M | ||
| Cash and Equivalents (USD) | 7.77M | ||
| Investments | 4.13M | ||
| Investments Current | 4.13M | ||
| Trade and Non-Trade Receivables | 3.66M | ||
| Current Assets | 30.24M | ||
| Total Assets | 30.24M | ||
| Current Liabilities | 87.84K | ||
| Total Liabilities | 87.84K | ||
| Accumulated Retained Earnings (Deficit) | 23.58M | ||
| Shareholders Equity | 30.16M | ||
| Shareholders Equity (USD) | 30.16M | ||